Cigna Corporation (CI) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Cigna Corporation (CI) Healthcare & Pipeline Overview

Cigna Corporation, a major player in the healthcare sector, delivers insurance and health services through its Evernorth and Cigna Healthcare segments. With a focus on coordinated care and global reach, Cigna serves diverse clients, including employers, health plans, and government organizations, maintaining a significant market presence.

What Is the Investment Thesis for CI?

With a P/E ratio of 11.58 and a dividend yield of 2.11%, the company offers a blend of value and income. The Evernorth segment's integrated pharmacy and care solutions drive consistent revenue, while Cigna Healthcare benefits from the growing demand for Medicare and individual health plans. Key catalysts include ongoing expansion in international markets and continued innovation in healthcare technology. However, potential risks include regulatory changes in the healthcare industry and increasing competition from other major health insurers. The company's beta of 0.27 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

CI Key Highlights

Market Cap of $74.2B reflects Cigna's significant presence in the healthcare industry.

• P/E Ratio of 11.58 indicates a potentially undervalued stock compared to its earnings.
• Dividend Yield of 2.11% provides a steady income stream for investors.
• Gross Margin of 9.3% demonstrates the profitability of Cigna's services.
• Beta of 0.27 suggests lower volatility compared to the broader market, making it a relatively stable investment.

Who Are CI's Competitors?

CI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CI's Key Strengths?

Diversified service offerings through Evernorth and Cigna Healthcare.

• Strong brand recognition and market presence.
• Extensive network of healthcare providers.
• Focus on data analytics and technology innovation.

What Are CI's Weaknesses?

High debt levels compared to some competitors.

• Exposure to regulatory changes in the healthcare industry.
• Dependence on government programs like Medicare and Medicaid.
• Profit Margin of 2.3% is relatively low compared to some peers.

What Could Drive CI Stock Higher?

Expansion of Evernorth's pharmacy and care solutions.

• Growth in Medicare Advantage enrollment.
• Potential acquisitions to expand service offerings.
• Continued investment in digital health technologies.
• Strategic partnerships to enhance value-based care models.

What Are the Key Risks for CI?

Insider selling — insiders were net sellers of roughly $4.2M recently.

• Regulatory changes impacting healthcare pricing and coverage.
• Increasing competition from other health insurers.
• Rising healthcare costs affecting profitability.
• Cybersecurity threats and data breaches.
• Economic downturn impacting enrollment and premium revenue.

What Are the Growth Opportunities for CI?

• Expansion of Evernorth Services: Cigna's Evernorth segment has significant growth potential through expanding its pharmacy benefits management, care delivery, and intelligence solutions. The market for pharmacy benefit management is projected to reach $600 billion by 2028, offering substantial opportunities for Cigna to increase its market share through innovative and cost-effective solutions. Timeline: Ongoing.
• Medicare Advantage Growth: The Medicare Advantage market is experiencing rapid growth, driven by increasing enrollment and favorable government policies. Cigna can capitalize on this trend by expanding its Medicare Advantage offerings and attracting more seniors seeking comprehensive healthcare coverage. The Medicare Advantage market is expected to reach $427 billion in 2026. Timeline: Ongoing.
• International Market Expansion: Cigna has the opportunity to expand its presence in international markets, particularly in regions with growing economies and increasing demand for healthcare services. By offering tailored health insurance solutions and leveraging its global network, Cigna can tap into new revenue streams and diversify its business. Timeline: Ongoing.
• Digital Health Innovation: Investing in digital health technologies, such as telehealth platforms and mobile health apps, can enhance Cigna's service offerings and improve customer engagement. The digital health market is projected to reach $660 billion by 2028, providing opportunities for Cigna to develop innovative solutions that improve healthcare access and outcomes. Timeline: Ongoing.
• Value-Based Care Models: Cigna can further integrate value-based care models into its operations, focusing on improving healthcare quality and reducing costs. By partnering with healthcare providers and implementing innovative payment models, Cigna can enhance its competitive position and drive better health outcomes for its members. Timeline: Ongoing.

What Are CI's Competitive Advantages?

• Scale: Cigna's large size and extensive network provide economies of scale and bargaining power.
• Brand Recognition: Cigna is a well-established and recognized brand in the healthcare industry.
• Integrated Services: The combination of Cigna Healthcare and Evernorth provides a comprehensive suite of services.
• Data Analytics: Cigna leverages data analytics to improve healthcare outcomes and reduce costs.

What Does CI Do?

Founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna Corporation has evolved into a leading global health service company. Originally established as Insurance Company of North America (INA), the company merged with Connecticut General Life Insurance Company (CG) in 1982 to form Cigna. Today, Cigna operates through two primary segments: Evernorth and Cigna Healthcare. Evernorth provides coordinated and point solution health services, including pharmacy benefits management, care delivery and management, and intelligence solutions. Cigna Healthcare offers medical, pharmacy, behavioral health, dental, vision, and health advocacy programs to insured and self-insured customers. The company also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans, as well as individual health insurance plans. Cigna extends its services internationally, offering healthcare coverage to mobile individuals and employees of multinational organizations. Its distribution network includes insurance brokers, consultants, direct sales to employers and individuals, and private and public exchanges. Cigna's commitment to innovation and customer-centric solutions has solidified its position in the competitive healthcare landscape.

What Products and Services Does CI Offer?

• Provides medical, pharmacy, and behavioral health services.
• Offers dental and vision insurance plans.
• Administers health advocacy programs.
• Provides Medicare Advantage and Medicare Part D plans.
• Offers individual health insurance plans.
• Provides healthcare coverage in international markets.
• Offers pharmacy benefit management services through Evernorth.
• Provides care delivery and management solutions.

How Does CI Make Money?

• Generates revenue through premiums from health insurance plans.
• Earns fees from pharmacy benefit management services.
• Receives payments for care delivery and management services.
• Profits from providing health solutions to employers and government organizations.

What Industry Does CI Operate In?

Cigna operates in the dynamic and highly competitive healthcare industry. The market is characterized by increasing demand for comprehensive health services, driven by an aging population and rising healthcare costs. Key trends include the growth of value-based care, the adoption of digital health technologies, and the expansion of Medicare Advantage plans. Cigna competes with other major health insurers like CVS Health Corporation (CVS) and Elevance Health Inc. (ELV), as well as pharmacy benefit managers and specialized healthcare providers. The industry is subject to significant regulatory oversight, impacting pricing, coverage, and operational practices.

Who Are CI's Key Customers?

• Employers offering health benefits to their employees.
• Individuals seeking health insurance coverage.
• Seniors enrolled in Medicare Advantage and Medicare Part D plans.
• Multinational organizations providing health benefits to their employees.
• Government organizations seeking healthcare solutions.

Company Profile

Cigna Corporation operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Bloomfield, US. The company is led by CEO Brian C. Evanko. CI has traded publicly since 1982.

Return on equity for Cigna Corporation stands at 15.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.1%, showing how much profit it generates from its asset base. CI trades at a trailing price-to-earnings ratio of 11.58, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 10.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.82 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 8.7%, the inverse of the P/E and a quick read on earnings relative to price.

CI Valuation & Market Position

With a $74.2B market cap, Cigna Corporation sits in the large-cap segment of the market. Analyst price targets span from $302.00 to $400.00, with a consensus of $338.33. At the current price of $280.91, that implies approximately 20% upside potential. Relative to its peer group, CI's quantitative score of 80/100 is roughly in line with the peer average of 75/100.

Quarterly Financial Performance: Cigna Corporation

Revenue for Cigna Corporation came in at $71.67B during Q2 FY2026, a 4.6% improvement versus the preceding quarter. The company recorded net income of $1.66B, with diluted EPS of $6.29. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, CI averaged $6.04 in diluted EPS.

Cigna Corporation's Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.77 places it in the grey zone, a middle ground that warrants monitoring.

Cigna Corporation has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 0.6% above estimates on average.

Over the past six months, Cigna Corporation insiders filed 12 SEC Form 4 transactions — 4 sales and 8 purchases. On net that is roughly 12K shares disposed (about $4.2M), a signal worth weighing alongside the fundamentals.

CI Financials

Next earnings report: Oct 29, 2026

CI earnings history & estimates →

CI Latest News

CI Analyst Consensus

CI MoonshotScore

Latest Cigna Corporation Analysis

Common Questions About CI (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources